Impact of COVID-19 on Liver Transplantation in Hong Kong and Singapore: A Modelling Study.

Impact of COVID-19 on Liver Transplantation in Hong Kong and Singapore: A Modelling Study.

10.1016/j.lanwpc.2021.100262

Saved in:

Bibliographic Details
Main Authors:	Tan, Eunice Xiang-Xuan, Quek, Wei Liang, Suryadi, Chahed, Haroun, Iyer, Shridhar Ganpathi, Jeyaraj, Prema Raj, Lee, Guan-Huei, Chan, Albert, Cheng, Stephanie, Hoe, Jan, Tan, Ek Khoon, Chew, Lock Yue, Fung, James, Chen, Melvin, Muthiah, Mark D, Huang, Daniel Q
Other Authors:	MEDICINE
Format:	Article
Published:	Elsevier BV 2021
Subjects:	COVID-19 Liver transplant hepatocellular carcinoma modelling outcomes survival
Online Access:	https://scholarbank.nus.edu.sg/handle/10635/207516
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore

Similar Items

Outcomes of salvage liver transplant for recurrent hepatocellular carcinoma: A comparison with primary liver transplant.
by: Guo, Yuxin, et al.
Published: (2023)

Repeat liver resection versus salvage liver transplant for recurrent hepatocellular carcinoma: A propensity score-adjusted and -matched comparison analysis.
by: Guo, Yuxin, et al.
Published: (2023)

Impact of COVID-19 on liver transplantation in Hong Kong and Singapore: a modelling study
by: Tan, Eunice Xiang-Xuan, et al.
Published: (2023)

Liver transplantation in Singapore 1990-2004
by: Wai, C.T., et al.
Published: (2016)

The Roles of Histone Deacetylases 1 and 2 in Hepatocellular carcinoma
by: LEUNG HO WING, CAROL
Published: (2012)

Liver transplantation for hepatocellular carcinoma in Singapore
by: Wai, C.T., et al.
Published: (2016)

Advanced techniques in the percutaneous ablation of liver tumours
by: Hui, Terrence C. H., et al.
Published: (2022)

Nitric oxide in Liver Cancer
by: GOH HWEY NEI, BEATRICE JOANNE
Published: (2011)

Highly well differentiated hepatocellular carcinoma and benign hepatocellular lesions: Can they be distinguished on fine needle aspiration biopsy?
by: Wee, A., et al.
Published: (2016)

Predicting HCC Response to Multikinase Inhibitors With In Vivo Cirrhotic Mouse Model for Personalized Therapy
by: Huang, Daniel Q, et al.
Published: (2021)

Diagnostic utility of immunohistochemistry in hepatocellular carcinoma, its variants and their mimics
by: Wee, A.
Published: (2012)

Klotho-beta overexpression as a novel target for suppressing proliferation and fibroblast growth factor receptor-4 signaling in hepatocellular carcinoma
by: Poh, W., et al.
Published: (2014)

Real-World Data on the Diagnosis, Treatment, and Management of Hepatocellular Carcinoma in the Asia-Pacific: The INSIGHT Study
by: Chow, Pierce K.H., et al.
Published: (2024)

ABERRANT DNA METHYLATION IN HEPATOCELLULAR CARCINOMA
by: MAH WAY CHAMP
Published: (2014)

Quality Assessment of Ultrasound and Magnetic Resonance Imaging for Hepatocellular Carcinoma Surveillance: A Systematic Review and Meta-Analysis
by: Quek, Jingxuan, et al.
Published: (2023)

MicroRNA-122 as a regulator of mitochondrial metabolic gene network in hepatocellular carcinoma
by: Burchard, J., et al.
Published: (2014)

EFFECTS OF TGFB1 ON TUMOR MICROENVIRONMENT AND LIVER CANCER INITIATION
by: YAN CHUAN
Published: (2016)

Liver Complications in Untreated Treatment-Ineligible versus Treated Treatment-Eligible Patients with Hepatitis B
by: Huang, Daniel Q., et al.
Published: (2023)

Liver transplantation in the developing world
by: Quak, S.H.
Published: (2011)

LIVER REGENERATION AND HEPATOCELLULAR CARCINOGENESIS IN ZEBRAFISH AFTER PARTIAL HEPATECTOMY
by: ZHU MINGKAI
Published: (2024)

Norcantharidin inhibits growth of human HepG2 cell-transplanted tumor in nude mice and prolongs host survival
by: Yang, E.-B., et al.
Published: (2014)

Development of a new patient-derived xenograft humanised mouse model to study human-specific tumour microenvironment and immunotherapy
by: Zhao Y., et al.
Published: (2019)

Number of Nodules, Child-Pugh Status, Margin Positivity, and Microvascular Invasion, but not Tumor Size, are Prognostic Factors of Survival after Liver Resection for Multifocal Hepatocellular Carcinoma
by: Goh, B.K.P., et al.
Published: (2016)

A Δraf1-ER-inducible oncogenic zebrafish liver cell model identifies hepatocellular carcinoma signatures
by: He, S., et al.
Published: (2014)

Outcome of liver transplantation for children with liver disease
by: Aw, M.M., et al.
Published: (2016)

Impact of Immune-Related Adverse Events on Efficacy of Immune Checkpoint Inhibitors in Patients with Advanced Hepatocellular Carcinoma
by: Ng K.Y.Y., et al.
Published: (2022)

Value of alpha-foetoprotein for screening of recurrence in hepatocellular carcinoma post resection
by: Chang, S.K.Y., et al.
Published: (2014)

Polymer- and lipid-based nanoparticle therapeutics for the treatment of liver diseases
by: Li, L., et al.
Published: (2014)

Global epidemiology and genetics of hepatocellular carcinoma
by: Toh, Ming Ren, et al.
Published: (2023)

Network-based pipeline for analyzing MS data: An application toward liver cancer
by: Goh, W.W.B., et al.
Published: (2013)

Proteomics signature profiling (PSP): A novel contextualization approach for cancer proteomics
by: Goh, W.W.B., et al.
Published: (2013)

Barcelona Clinic Liver Cancer outperforms Hong Kong Liver Cancer staging of hepatocellular carcinoma in multiethnic Asians: Real-world perspective
by: Li, James Weiquan, et al.
Published: (2023)

Prognosis prediction of hepatocellular carcinoma based on magnetic resonance imaging features
by: Low, Hsien Min, et al.
Published: (2023)

Expanding the donor pool for liver transplantation in the setting of an "opt-out" scheme - 3 Years after new legislation
by: Lee, V.T.W., et al.
Published: (2011)

A meta-analysis on the prevalence of chronic kidney disease in liver transplant candidates and its associated risk factors and outcomes
by: Teo, Vanessa Xin Yi, et al.
Published: (2022)

Combined hepatocellular-cholangiocarcinoma: Diagnostic challenge in hepatic fine needle aspiration biopsy
by: Wee, A., et al.
Published: (2012)

Targeted inhibition of purine metabolism is effective in suppressing hepatocellular carcinoma progression
by: Chong, Yong Chun, et al.
Published: (2020)

A meta-analysis on the rate of hepatocellular carcinoma recurrence after liver transplant and associations to etiology, alpha-fetoprotein, income and ethnicity
by: Tan, Darren J. H., et al.
Published: (2022)

ASSOCIATION OF LONG NON-CODING RNAS WITH PROGNOSIS OF HEPATOCELLULAR CARCINOMA PATIENTS
by: LIM LEE JIN
Published: (2020)

Aflatoxin-B exposure does not lead to p53 mutations but results in enhanced liver cancer of Hupki (human p53 knock-in) mice
by: Tong, W.-M., et al.
Published: (2014)